Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study

Citation:

Chatziralli I, Theodossiadis G, Kabanarou SA, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:2077–2078.